Sterling Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Buy
2,327
+21
+0.9% +$21.5K 0.66% 25
2026
Q1
$2.12M Buy
2,306
+19
+0.8% +$19.3K 0.59% 29
2025
Q4
$2.44M Buy
2,287
+75
+3% +$71.7K 0.7% 24
2025
Q3
$1.69M Buy
2,212
+1,793
+428% +$1.33M 0.54% 37
2025
Q2
$327K Sell
419
-1,632
-80% -$1.27M 0.19% 89
2025
Q1
$1.69M Buy
+2,051
New +$1.71M 0.58% 37
2024
Q4
Sell
-1,434
Closed -$1.27M 154
2024
Q3
$1.27M Buy
1,434
+284
+25% +$255K 0.45% 44
2024
Q2
$1.04M Sell
1,150
-2
-0.2% -$1.6K 0.41% 46
2024
Q1
$896K Buy
1,152
+2
+0.2% +$1.42K 0.41% 47
2023
Q4
$670K Hold
1,150
0.34% 56
2023
Q3
$618K Hold
1,150
0.35% 58
2023
Q2
$539K Hold
1,150
0.29% 60
2023
Q1
$395K Hold
1,150
0.23% 85
2022
Q4
$421K Sell
1,150
-43
-4% -$15.2K 0.26% 75
2022
Q3
$385K Hold
1,193
0.28% 67
2022
Q2
$386K Hold
1,193
0.29% 80
2022
Q1
$341K Sell
1,193
-4
-0.3% -$1.03K 0.23% 104
2021
Q4
$331K Buy
+1,197
New +$303K 0.22% 100

Other funds holding LLY

Sterling Investment Counsel's LLY Position: Q2 2026 in Review

Sterling Investment Counsel increased its Eli Lilly (LLY) stake by 0.91% in Q2 2026, buying an estimated $21.5K and bringing the position to 2,327 shares worth $2.79M. The position accounts for 0.66% of the portfolio, ranked #25.

Sterling Investment Counsel first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sterling Investment Counsel held 2,327 shares of Eli Lilly worth $2.79M as of Q2 2026.
  • Sterling Investment Counsel bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.66% of Sterling Investment Counsel's portfolio in Q2 2026, its #25 holding.
  • Sterling Investment Counsel first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.